Trial Profile
Clevidipine in Aneurysmal Subarachnoid Hemorrhage, A Pilot Study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2023
Price :
$35
*
At a glance
- Drugs Clevidipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms CLASH
- 31 Jan 2023 Status changed from recruiting to discontinued.
- 19 Sep 2009 New trial record